Clinical Trial for Comparison of RPH-001 to Avastin® - Trial 2017-001634-26

Name: Clinical Trial 2017-001634-26
Creator: TRPHARM
Keywords: Non-Small Cell Lung Cancer, clinical trial

Access comprehensive clinical trial information for 2017-001634-26 through Pure Global AI's free database. This phase not specified trial is sponsored by TRPHARM and is currently status unknown. The study focuses on Non-Small Cell Lung Cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2017-001634-26

Trial Details

EU Clinical Trials Register • 2017-001634-26

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Clinical Trial for Comparison of RPH-001 to Avastin®

Study Focus

Disease/Condition

Non-Small Cell Lung Cancer

Sponsor & Location

Primary Sponsor

TRPHARM

Timeline & Enrollment

Phase

N/A

Start Date

N/A

End Date

N/A

Primary Outcome

E-1. Any history or presence of clinically relevant cardiovascular, pulmonary, gastrointestinal, hepatic, renal, metabolic, hematological, neurological, osteomuscular, articular, psychiatric, systemic, ocular, or infectious disease, or signs of acute illness.

ICD-10 Classifications

Secondary malignant neoplasm of lung

Malignant neoplasm: Lower lobe, bronchus or lung

Malignant neoplasm: Middle lobe, bronchus or lung

Malignant neoplasm: Bronchus or lung, unspecified

Malignant neoplasm of bronchus and lung

Data Source

Registry

EU Clinical Trials Register

Trial ID

2017-001634-26

Type

Non-Device Trial